| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 02/11/2009 | CN101361812A Preparation method of rhubarb glycyrrhiza preparation |
| 02/11/2009 | CN101361810A Traditional Chinese medicine combination for treating virus lower respiratory tract infection and preparation method thereof |
| 02/11/2009 | CN101361801A Qiancao Naomaitong medicine for treating apoplexy or the like and preparation method thereof |
| 02/11/2009 | CN101361796A Medicine for treating upper respiratory tract infection and preparation method thereof |
| 02/11/2009 | CN101361789A Traditional Chinese medicine formulation for treating and preventing lung impairment after tumor controlling radiotherapy |
| 02/11/2009 | CN101361786A Total-flavone extraction and purification and its monomer separation method from Lespedaza bedysaroides |
| 02/11/2009 | CN101361767A Medicine for relieving cough, eliminating sputum, relieving dyspepsia, promoting blood and dissipating blood stasis and preparation method thereof |
| 02/11/2009 | CN101361742A Aminophylline oral solution and preparation method thereof |
| 02/11/2009 | CN101361739A Anti-bacteria agent for parenteral administration |
| 02/11/2009 | CN101361737A Use of 4-tetrahydrothiazole dione derivates |
| 02/11/2009 | CN100460002C Chinese medicine composition for treating various kinds of inflammation and cyst |
| 02/11/2009 | CN100459996C Chinese herbal medicine preparation for treating rhinitis and preparing method thereof |
| 02/11/2009 | CN100459973C External-use ointment and preparing method thereof |
| 02/10/2009 | US7488811 Lacking cladinose in position 3, de(N-methyl)-descladinosyl-9-dihydro-erythromycin A; free of antibiotic properties; diseases related to an impaired cellular functionality of neutrophils, for instance rheumatoid arthritis, reperfusion ischaemia injury, septic shock, atherosclerosis |
| 02/10/2009 | US7488758 Levalbuterol hydrochloride polymorph B |
| 02/10/2009 | US7488735 antagonists of M3 muscarinic receptors; N-(1-Azabicyclo[2.2.2]oct-3-yl)-2-hydroxy-2,2-dithien-2-ylacetamide; respiratory disorders, urological disorders, gastrointestinal disorders, cardiovascular disorders; alkylation |
| 02/10/2009 | US7488734 Anticancer agents; hormone replacement therapy; contraceptives |
| 02/10/2009 | CA2389709C Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 02/10/2009 | CA2386690C Pharmaceutical tramadol salts |
| 02/10/2009 | CA2385732C Bicyclic compounds composition and method for stabilizing the same |
| 02/05/2009 | WO2009017219A1 Inhibitor of binding of s1p1 |
| 02/05/2009 | WO2009016191A1 Process for preparing a leukotriene antagonist and an intermediate thereof |
| 02/05/2009 | WO2009015812A2 Prodrugs of 2-amino-6- ( { [2- (4-chlorphenyl) -1, 3-thiaz0l-4-yl] methyl}thio) -4- [4- ( 2 -hydroxyethoxy) phenyl] pyridin-3, 5-dicarbonitrile |
| 02/05/2009 | WO2008131376A3 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 02/05/2009 | WO2008116912A3 Purinyl derivatives and their use as potassium channel modulators |
| 02/05/2009 | WO2003099808A8 Substituted heterocyclic compounds and methods of use |
| 02/05/2009 | US20090036538 Treatment methods using triaryl methane compounds |
| 02/05/2009 | US20090036535 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease |
| 02/05/2009 | US20090036518 Pharmaceutical composition containing flavonoids |
| 02/05/2009 | US20090036517 Anti-angiogenic compositions and methods of use |
| 02/05/2009 | US20090036472 Azabicyclo derivatives as anti-inflammatory agents |
| 02/05/2009 | US20090036469 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists |
| 02/05/2009 | US20090036453 Pyrrolopyridazinone Compound |
| 02/05/2009 | US20090036442 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/05/2009 | US20090036406 Injection |
| 02/05/2009 | US20090035391 Nasal Irrigation Solutions And Methods Of Using Same |
| 02/05/2009 | US20090035347 Isolated stromal cells and methods of using the same |
| 02/05/2009 | US20090035316 Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer (SCLC) |
| 02/05/2009 | US20090035313 Compounds |
| 02/05/2009 | US20090035264 Aerosolizing dry powder of interleukin-4 receptor with carbohydrage, lipid, buffer, peptide, protein, Group II metal, or oligopeptide excipient; small aerodynamic particle size; dispersion into gas stream to make inhalant; high dispersibilities |
| 02/05/2009 | US20090035224 Methods of Using Albuterol and Calcium Activated Potassium Channel Openers |
| 02/05/2009 | DE19963179B4 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases |
| 02/05/2009 | CA2698170A1 Prodrugs of 2-amino-6- ( { [2- (4-chlorphenyl) -1, 3-thiaz0l-4-yl] methyl}thio) -4- [4- ( 2 -hydroxyethoxy) phenyl] pyridin-3, 5-dicarbonitrile |
| 02/05/2009 | CA2695008A1 Substituted indoles |
| 02/04/2009 | EP2020438A1 Treatment of pompe's disease |
| 02/04/2009 | EP2020409A1 New piperidinyl derivatives as modulators of chemokine receptor activity |
| 02/04/2009 | EP2020408A1 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 02/04/2009 | EP2020243A1 Topically applicable pharmaceutical preparation |
| 02/04/2009 | EP2020242A2 Improved Topical Medicaments and Methods for Photodynamic Treatment of Disease |
| 02/04/2009 | EP2020239A1 Use of IL-174 agonists for treating infectious diseases |
| 02/04/2009 | EP2020229A1 Multiparticulate modified release composition |
| 02/04/2009 | EP2019837A1 Compounds and compositions as channel activating protease inhibitors |
| 02/04/2009 | EP2019835A1 Oligonucleotides affecting expression of phosphodiesterases |
| 02/04/2009 | EP2019834A1 Ectonucleotidase inhibitors |
| 02/04/2009 | EP1492773B1 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| 02/04/2009 | CN201189303Y External traditional Chinese medicine plaster for treating mouth and tongue sore |
| 02/04/2009 | CN101360744A Pure and stable tiotropium bromide |
| 02/04/2009 | CN101360709A Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (PBR) |
| 02/04/2009 | CN101357220A Medicine for treating tracheitis |
| 02/04/2009 | CN101357202A Chinese traditional medicine for treating hepatosis and preparation method thereof |
| 02/04/2009 | CN101357200A Medicine for treating chronic faucitis |
| 02/04/2009 | CN101357163A External medicine for treating wind-cold type common cold and preparation method thereof |
| 02/04/2009 | CN101357146A Preparation method of chimonanthus nitens valid target, production method and use of formulation thereof |
| 02/04/2009 | CN101357130A Oral microparticles containing pseudoephedrine hydrochloride and cetirizine hydrochloride |
| 02/04/2009 | CN100459776C Access parameter adaptation and packet data resource management by utilizing detailed mobile status information |
| 02/04/2009 | CN100457180C Medicine composition for treating allergic disease and method for preparing the same |
| 02/04/2009 | CN100457167C Externally used traditional Chinese medicine preparation for treating nasal mucosa erosion and nosebleed and its preparation method |
| 02/04/2009 | CN100457159C Chronic pharyngolaryngitis effervescence tablet and preparation method and its quality control method |
| 02/04/2009 | CN100457151C Chinese goldthread soft capsule for clearing away adverse lung energy and its preparation process |
| 02/04/2009 | CN100457139C Method for preparing a Shuanhuanglian injection and the component detecting method |
| 02/04/2009 | CN100457126C Composition of ephedra total alkaloid and earthworm acid part and preparation method thereof |
| 02/04/2009 | CN100457123C Calmophil, pharmaceutical composition for treating pulmonary surfactant system disorder and producing method thereof |
| 02/04/2009 | CN100457088C Pharmaceutical composition comprising lipids comprising polar and nonpolar moiety parts |
| 02/03/2009 | US7485730 Pharmaceutical compounds |
| 02/03/2009 | US7485724 2,4-pyrimidinediamine compounds and their uses |
| 02/03/2009 | US7485647 2-aminoquinoline derivatives |
| 02/03/2009 | US7485644 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation |
| 02/03/2009 | US7485639 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |
| 02/03/2009 | US7485628 Inhibition of STAT-1 |
| 02/03/2009 | US7485314 Induction of antigen specific immunologic tolerance |
| 02/03/2009 | US7485301 Complexing, therapy, prophylaxis, medical diagnosis; antibodies, antigen binding to chemokine |
| 02/03/2009 | CA2425164C (4-acylaminopiperidin-1-yl)acetamides as neurokinin antagonists |
| 02/03/2009 | CA2420040C New phenylalanine derivatives |
| 02/03/2009 | CA2395881C Inhalation particles |
| 01/30/2009 | CA2712022A1 Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and a pharmaceutical composition comprising it - 026 |
| 01/29/2009 | WO2009015028A1 Substituted cyclohexenes |
| 01/29/2009 | WO2009013444A1 Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors |
| 01/29/2009 | WO2009013335A1 Organic compounds |
| 01/29/2009 | WO2009012656A1 Inhibitors for matrix metalloproteinases, pharmaceutical compositions containing them and their uses |
| 01/29/2009 | WO2008142094A4 Triazol compounds for treating biofilm formation |
| 01/29/2009 | WO2008104278A8 Imidazo[1,2-a] pyridines and their use as pharmaceuticals |
| 01/29/2009 | WO2008092015A3 Use of hsp20 peptides for treating airway smooth muscle disorders in subjects desensitized to ss -adrenergic receptor agonist therapy |
| 01/29/2009 | US20090030051 Inhibitors of IMPDH enzyme |
| 01/29/2009 | US20090030048 Novel pharmaceutical compounds |
| 01/29/2009 | US20090030029 Novel benzonaphthyridines |
| 01/29/2009 | US20090030023 Pyrimidine compounds and medicinal composition thereof |
| 01/29/2009 | US20090029996 Pyridazin-3(2H)-One Derivatives And Their Use As Pde4 Inhibitors |
| 01/29/2009 | US20090029995 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 01/29/2009 | US20090029990 Dihydropteridinones in the treatment of respiratory diseases |
| 01/29/2009 | US20090029986 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |